<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 8)
PSYCHEMEDICS CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK - $.005 PAR VALUE
- --------------------------------------------------------------------------------
744375106
- --------------------------------------------------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement / /. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of less than five percent of such class.)
(See Rule 13d-7).
<PAGE> 2
SCHEDULE 13G
CUSIP No. 744375106
1) Names of Reporting Persons; S.S. or I.R.S. Identification Nos. of Above
Persons
Werner A. Baumgartner
2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b) X
3) SEC Use Only
4) Citizenship or Place of Organization U.S.A.
Number of Shares 5) Sole Voting Power 149,500
Beneficially Owned
By Each Reporting 6) Shared Voting Power 1,517,167
Person With
7) Sole Dispositive Power 149,500
8) Shared Dispositive Power 1,517,167
9) Aggregate Amount Beneficially Owned by Each Reporting Person
1,666,667
10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
11) Percent of Class Represented by Amount in Row (9) 8.4%
12) Type of Reporting Person (See Instructions) IN
<PAGE> 3
SCHEDULE 13G
CUSIP No. 744375106
1) Names of Reporting Persons; S.S. or I.R.S. Identification Nos. of Above
Persons
Annette Baumgartner ###-##-####
2) Check the Appropriate Box if a Member of a Group (See Instructions)
(a)
(b) X
3) SEC Use Only
4) Citizenship or Place of Organization
Number of Shares 5) Sole Voting Power 0
Beneficially Owned
By Each Reporting 6) Shared Voting Power 1,517,167
Person With
7) Sole Dispositive Power 0
8) Shared Dispositive Power 1,517,167
9) Aggregate Amount Beneficially Owned by Each Reporting Person
1,517,167
10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
11) Percent of Class Represented by Amount in Row (9) 7.7%
12) Type of Reporting Person (See Instructions) IN
<PAGE> 4
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 13G
AMENDMENT NO. 8
Item 1 (a) Name of Issuer: Psychemedics Corporation
(b) Address of Issuer's Principal Executive Offices:
1280 Massachusetts Avenue
Cambridge, Massachusetts 02138
Item 2 (a) Name of Person Filing: Werner A. Baumgartner and Annette
Baumgartner
(b) Address of Principal Business Office or, if none,
Residence: 24622 Skyline View Drive
Malibu, California 90265
(c) Citizenship: USA
(d) Title of Class of Securities, Common Stock, $.005 par value
(e) CUSIP NUMBER: 744375106
Item 3 If this statement is filed pursuant to Rule 13d-1(b),
or 13d-2(b), check whether the person filing is a:
Not Applicable
Item 4 Dr. Baumgartner is the beneficial owner of options to require 149,500
shares of Common Stock. Dr. and Mrs. Baumgartner are Trustees of
family and charitable trusts which own an aggregate of 1,517,107
shares of Common Stock.
<PAGE> 5
Item 5 Ownership of Five Percent or Less of a Class:
Not Applicable
Item 6 Ownership of More than Five Percent on Behalf of Another Person:
Not Applicable
Item 7 Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company:
Not Applicable
Item 8 Identification and Classification of Members of the Group:
This Schedule 13G is being filed by Werner and Annette
Baumgartner. Dr. and Mrs. Baumgartner each expressly disclaims
beneficial ownership of the securities held by the other, and
each disclaims the existence of a group.
Item 9 Notice of Dissolution of Group:
Not Applicable
Item 10 Certification
Not Applicable
After reasonable inquiry and to the best of my knowledge and belief, I
hereby certify that the information set forth in this statement is true,
complete and correct.
January 15, 1996
-------------------------
Date
/s/ Werner A. Baumgartner
-------------------------
Signature
Werner A. Baumgartner
-------------------------
Name/Title
/s/ Annette Baumgartner
-------------------------
Signature
Annette Baumgartner
-------------------------
Name/Title
